LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection

被引:4
作者
Zhang, Chunhui [1 ]
Yang, Rui [1 ]
Wang, Xinxin [2 ]
Tao, Yuqing [1 ]
Tang, Shuli [3 ]
Tian, Zhennan [4 ]
Zhou, Yang [2 ]
机构
[1] Harbin Med Univ Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ Canc Hosp, Dept Pathol, Harbin, Heilongjiang, Peoples R China
关键词
Hepatocellular carcinoma; Magnetic resonance imaging; Morphological classification; Prediction; Prognosis; MACROSCOPIC CLASSIFICATION; INTRAHEPATIC RECURRENCE; RISK-FACTORS; PHASE;
D O I
10.1245/s10434-023-13494-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThis study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after radical surgery of hepatocellular carcinoma (HCC).Patients and MethodsA retrospective analysis of 296 patients with HCC who underwent radical resection was performed. On the basis of LI-RADS, tumor imaging morphology was classified into three types. The clinical imaging features, ER, and survival rates of three types were compared. Univariate and multivariate Cox regression analyses were conducted to identify prognostic factors associated with OS and ER after hepatectomy for HCC.ResultsThere were 167 tumors of type 1, 95 of type 2, and 34 of type 3. In patients with type 3 HCC, postoperative mortality and ER were significantly higher than in patients with type 1 and type 2 (55.9% versus 32.6% versus 27.5% and 52.9% versus 33.7% versus 28.7%). In multivariate analysis, the LI-RADS morphological type was a stronger risk factor for predicting poor OS [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.59-4.85, P < 0.001] and ER (HR 2.14, 95% CI 1.24-3.70, P = 0.007). A subgroup analysis revealed that type 3 was associated with poor OS and ER in > 5 cm cases but not in < 5 cm cases.ConclusionsER and OS of patients with HCC undergoing radical surgery can be predicted using the preoperative tumor LI-RADS morphological type, which could help to select personalized treatment plans for patients with HCC in the future.
引用
收藏
页码:4876 / 4885
页数:10
相关论文
共 50 条
[21]   Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy [J].
Razek, A. A. K. Abdel ;
El-Serougy, L. G. ;
Saleh, G. A. ;
Shabana, W. ;
Abd El-Wahab, R. .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2020, 101 (09) :547-553
[22]   Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS [J].
Choi, Se Jin ;
Choi, Sang Hyun ;
Kim, Dong Wook ;
Byun, Jae Ho ;
Won, Hyung Jin ;
Shin, Yong Moon .
JOURNAL OF HEPATOLOGY, 2023, 78 (03) :596-603
[23]   Prognostic implications of CT/MRI LI-RADS in hepatocellular carcinoma: State of the art and future directions [J].
Wei, Hong ;
Yang, Ting ;
Chen, Jie ;
Duan, Ting ;
Jiang, Hanyu ;
Song, Bin .
LIVER INTERNATIONAL, 2022, 42 (10) :2131-2144
[24]   Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma [J].
Cunha, Guilherme Moura ;
Chernyak, Victoria ;
Fowler, Kathryn J. ;
Sirlin, Claude B. .
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 :513-527
[25]   Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: A retrospective study [J].
Kawano, Y. ;
Sasaki, A. ;
Kai, S. ;
Endo, Y. ;
Iwaki, K. ;
Uchida, H. ;
Shibata, K. ;
Ohta, M. ;
Kitano, S. .
EJSO, 2009, 35 (02) :174-179
[26]   LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid–enhanced MRI for early recurrence risk stratification after curative resection [J].
Hong Wei ;
Hanyu Jiang ;
Tianying Zheng ;
Zhen Zhang ;
Caiwei Yang ;
Zheng Ye ;
Ting Duan ;
Bin Song .
European Radiology, 2021, 31 :2289-2302
[27]   Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System [J].
Sun, Yajuan ;
Yu, Can ;
Wang, Xinxin ;
Yang, Rui ;
Ding, Zhipeng ;
Zhou, Yang .
JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (12) :2787-2796
[28]   Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma [J].
Sugimoto, Katsutoshi ;
Kamiyama, Naohisa ;
Kakegawa, Tatsuya ;
Takahashi, Hiroshi ;
Wada, Takuya ;
Abe, Masakazu ;
Yoshimasu, Yu ;
Takeuchi, Hirohito ;
Itoi, Takao .
ULTRASONOGRAPHY, 2023, 42 (03) :388-399
[29]   Gadoxetic acid-enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma [J].
Wang, Ruizhi ;
Xu, Hengtian ;
Chen, Wufei ;
Jin, Liang ;
Ma, Zhuangxuan ;
Wen, Lei ;
Wang, Hongwei ;
Cao, Kun ;
Du, Xia ;
Li, Ming .
FRONTIERS IN ONCOLOGY, 2023, 13
[30]   Surgical Resection vs. Percutaneous Ablation for Single Hepatocellular Carcinoma: Exploring the Impact of Li-RADS Classification on Oncological Outcomes [J].
Centonze, Leonardo ;
Di Sandro, Stefano ;
Lauterio, Andrea ;
De Carlis, Riccardo ;
Frassoni, Samuele ;
Rampoldi, Antonio ;
Tuscano, Bruno ;
Bagnardi, Vincenzo ;
Vanzulli, Angelo ;
De Carlis, Luciano .
CANCERS, 2021, 13 (07)